Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The genes encoding the histone acetyltransferases (HATs) CREBB-binding protein (CREBBP) and EP300 are commonly mutated in germinal-center-derived B cell lymphomas, and their inactivation is thought to contribute to lymphomagenesis. In this issue of Immunity, Meyer et al. (2019) demonstrate that the somatic inactivation of one histone modifying enzyme might leave lymphomas uniquely sensitive to antagonists of the other.

Original publication

DOI

10.1016/j.immuni.2019.08.018

Type

Journal article

Journal

Immunity

Publication Date

17/09/2019

Volume

51

Pages

420 - 423

Keywords

B-Lymphocytes, CREB-Binding Protein, Carrier Proteins, E1A-Associated p300 Protein, Epigenesis, Genetic, Germinal Center, Humans, Lymphoma, Large B-Cell, Diffuse